[HTML][HTML] Chronic respiratory symptoms, spirometry and knowledge of COPD among general population

M Miravitlles, C de la Roza, J Morera, T Montemayor… - Respiratory …, 2006 - Elsevier
… Author links open overlay panel Marc Miravitlles a , Cristian de la Roza a , Josep Morera
b , Teodoro Montemayor c , Elena Gobartt d , Antonio Martín e , José Luis Alvarez-Sala f …

[HTML][HTML] Colour of sputum is a marker for bacterial colonisation in chronic obstructive pulmonary disease

…, S Vilà, C de la Roza, R Hervás, C Esquinas… - Respiratory …, 2010 - Springer
Background Bacterial colonisation in chronic obstructive pulmonary disease (COPD)
contributes to airway inflammation and modulates exacerbations. We assessed risk factors for …

[HTML][HTML] Use of spirometry and patterns of prescribing in COPD in primary care

M Miravitlles, C de la Roza, K Naberan, M Lamban… - Respiratory …, 2007 - Elsevier
… Marc Miravitlles a , Cristian de la Roza a , Karlos Naberan b , Maite Lamban c , Elena Gobartt
d , Antonio Martin e … Tratamiento de la bronquitis crónica y la EPOC en Atención Primaria …

Results of a case-detection programme for α1-antitrypsin deficiency in COPD patients

C De la Roza, F Rodríguez-Frías, B Lara… - European …, 2005 - Eur Respiratory Soc
… Estudio de la frecuencia de los diferentes fenotipos de la alfa-1-antitripsina en una población
de Barcelona. [Study of the frequency of different phenotypes of alpha-1-antitrypsin in a …

Attitudes toward the diagnosis of chronic obstructive pulmonary disease in primary care

M Miravitlles, C De la Roza, K Naberan… - Archivos de …, 2006 - Elsevier
… Tras la historia y la exploración física … de la espirometría que mostraban una obstrucción
de carácter moderado o grave. Los resultados ne-gativos de una prueba broncodilatadora y de

Clinical outcomes and cost analysis of exacerbations in chronic obstructive pulmonary disease

…, A Domenech, G Villegas, F Conget, C de la Roza - Lung, 2013 - Springer
… increased sputum (95.6 %) and fever >38 C (48.9 %) in the moxifloxacin group compared …
Cristian de la Roza is a full time employee of Bayer Healthcare. The other authors have no …

Alpha-1-antitrypsin deficiency: optimal therapeutic regimen based on population pharmacokinetics

D Soy, C De la Roza, B Lara, C Esquinas, A Torres… - Thorax, 2006 - thorax.bmj.com
… in which D is the administered dose (mg); V c is the volume of distribution at the central
compartment (L); k 12 is the fractional rate constant from the central compartment (1) to the …

Glutathione S-transferase P1 and lung function in patients with α1-antitrypsin deficiency and COPD

F Rodriguez, C de la Roza, R Jardi, M Schaper, R Vidal… - Chest, 2005 - Elsevier
… at 95C for 7 min, followed by 45 amplification cycles at 94C for 5 s, 55C for 10 s, and 72C for
… 40C for 20 s to facilitate binding of the hybridization probes, and than slowly increased (0.1…

Efficacy of moxifloxacin in the treatment of bronchial colonisation in COPD

…, C de la Roza, R Hervás, C Esquinas… - European …, 2009 - Eur Respiratory Soc
This study was designed to investigate the efficacy of moxifloxacin for the eradication of
bacterial colonisation of the airways in patients with moderate-to-severe chronic obstructive …

Ethanol and ethyl acetate production during the cider fermentation from laboratory to industrial scale

C de la Roza, A Laca, LA Garcı́a, M Dı́az - Process Biochemistry, 2003 - Elsevier
… r ea =2k ea C s C e C x where r x , r e and r ea are biomass, ethanol and ethyl acetate
generation rates, respectively; r s is sugar consumption rate; C x , C s , C e and C ea are biomass, …